Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials.

BMC Endocr Disord · 2022 · PMC8996397 · PMID 35399069

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

nominally significantP < 0.01actually significant

In the therapies that improve NAFLD, 79.2% (38/48) treatment interventions had nominally significant summary results at P < 0.01 and 20.8% (10/48) at 0.01 ≤ P < 0.05.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.